A significant advance in cancer research is emerging with the use of mini-antibodies to re-engage damaged p53. This vital malignant suppressor protein is frequently disabled in many kinds of malignancies, resulting https://socialmarkz.com/story12671975/mini-antibodies-restore-the-p53-protein-new-potential-hope-for-tumor-management